Expanded solutions for seamless stem cell research
AMSBIO, a leading provider of innovative products and services for the life sciences community, announces the launch of its Expanded Stem Cell Synergy Solutions.
Over the last two decades AMSBIO has established itself as a leading international supplier of solutions for streamlined and efficient ES/iPS Cell Culture using feeder-free StemFit® media and iMatrix recombinant laminin extracellular matrices. Backed by knowledgeable support teams in the UK, USA, and Germany – AMSBIO has expanded its products and services across the entire stem cell…
In October 2023, the Financial Reporting Council (FRC) announced a delay to the publication and effective date of the future changes to UK GAAP from its periodic review.
The revised suite of standards reflecting the second periodic review of UK GAAP is now expected to be issued in the first half of 2024 and implemented not before periods commencing on or after 1 January 2026, instead of 1 January 2025 as originally planned.
Understanding the delay
The delayed issue date has provided the FRC with more time as it considers over 50 responses to its consultation on the…
Kadans Science Partner adds to Oxfordshire’s laboratory supply with the completion of Barton House
Owned and developed by Kadans Science Partner, the brand new, purpose built laboratory accommodation is designed to a highly technical specification, including an on-site café, cycle storage and EV charging points.
London, 12 February 2024 – Barton House, located on Abingdon Science Park, is the latest purpose-built laboratory facility to come to the market in Oxfordshire. Kadans Science Partner (“Kadans”) continues to expand this established cluster of innovative businesses on Abingdon…
• Key deals cause a surge in Golden Triangle leasing activity, bolstered by the 352,000 sq ft transacted in final quarter of last year
• Development pipeline totals 3.1 million sq ft across Golden Triangle
Demand for life sciences space in the ‘Golden Triangle’ surged in 2023, with the 925,000 sq ft of space representing the highest annual volume since 2015, according to the latest figures from Cushman & Wakefield.
Take up of laboratory space was bolstered by a robust final quarter, with 352,000 sq ft transacting equating to more than double Q3 and the five-year average. Activity in Q4…
Pioneer Group, a leading developer and operator of life science and high-tech campuses, has secured planning permission from Cambridge City Council, subject to S106, for the redevelopment of the Grafton Centre in the city.
The Planning Committee at Cambridge City Council yesterday (7 Feb) voted in favour of the multi-million-pound regeneration for the shopping centre, which will be converted into laboratory and office space for life science and tech companies. The western end of the centre will be retained and transformed into a more attractive destination for local shoppers.
The…
Barcelona and Nottingham, February 8th, 2024
Source BioScience, an industry-leading provider of genomic services and healthcare diagnostics,
and Inbiomotion, a company commercializing its proprietary MAF Test® for identifying high risk
early-stage breast cancer patients, have signed an exclusive agreement to start offering the MAF
Test® as a service in United Kingdom and Ireland. The MAF Test® predicts the prognosis of breast
cancer patients and helps oncologists to identify those patients who may be able to prevent
recurrence and benefit from adjuvant treatment with bisphosphonates, which…
Read February eNews: Where to find Your Life Science Connections, featuring:
✅ Welcome from Tony Jones, CEO, One Nucleus
✅ Moving Forward Together
✅ Is it Rocket Science?
✅ Use One Nucleus' High Profile Initiatives to Reach Your Audience
✅ Narrowing the Odds on Success
✅ Nominate Your Life Sciences Inspiration of the Year Award 2024
✅ Upcoming Events for Your Diary
New NGS Laboratory opens its doors for genomics researchers.
Azenta Life Sciences will officially open its new GENEWIZ Multiomics and Synthesis Solutions laboratory in Oxford, UK in March 2024. As a global provider of R&D genomics services, Azenta leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Dr Ginger Zhou, Senior Vice President and General Manager for GENEWIZ Multiomics & Synthesis Solutions said, “The opening of our genomics lab in Oxford…
1 February 2024 - Cambridge, UK - Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced today that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to its next phase of development. The appointment is part of a planned succession process, with co-founder Dr John McCafferty transitioning from Chief Executive Officer to Chief Technology Officer after having co-founded Maxion, raised $16 million in initial…
29 February 2024 | The Garden Room, St John’s Innovation Centre, Cambridge
It’s never too early to start planning your business exit. Business exit strategy experts Yellowyoyo have teamed up with Innovate UK EDGE to deliver an essential event for founders that will set you on the road to maximising value, whether you plan to exit in five years or fifty years. Do you plan to sell your business, pass it to your chosen successor, merge with another company or stay on in a new role? Whatever your preferred exit, the time to start preparing is now.
The agenda will include valuable group…